M
Mohamed Milad Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
3 h-index
11 pubs
101 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Mohamed Milad's research interests span multiple disciplines, including the development of dual inhibitors for metabolic pathways and the study of cancer treatments. He has investigated thiazole-fused derivatives as inhibitors of actin cytoskeleton, with applications in melanoma tumor treatment. Milad has also explored the synthesis and development of compounds targeting fatty acid biosynthesis for MRSA infection clearance. His work includes research on bone remineralization related to multiple myeloma and has touched upon agricultural applications, such as determining nitrogen deficiencies in maize using remote sensing indices. Milad's scholarship metrics include an h-index of 3 across 10 publications with 93 citations. He has collaborated with researchers at Arkansas State University and the University of Arkansas for Medical Sciences.
Metrics
- h-index: 3
- Publications: 11
- Citations: 101
Selected Publications
-
Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
-
Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
-
Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
-
Determining nitrogen deficiencies for maize using various remote sensing indices (2022)
-
Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience (2021)
-
Testing differentially methylated regions through functional principal component analysis (2021)
Collaboration Network
Top Collaborators
Shailesh Budhathoki
Arkansas State University
5 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Alexei G. Basnakian
Arkansas State University
5 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Mohammad A. Alam
Arkansas State University
5 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection
Sanjay Adhikary
Arkansas State University
4 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Subrata Roy
Arkansas State University
4 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Alan J. Tackett
University of Arkansas for Medical Sciences
4 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Nathan L. Avaritt
University of Arkansas for Medical Sciences
4 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
S. Chowdhury
Arkansas State University
3 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Author response for "Thiazole-fused Androstenone and Ethisterone Derivatives: Potent β- and γ-Actin Cytoskeleton Inhibitors to Treat Melanoma Tumors"
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Gayla R. Olbricht
2 shared publications
- Testing differentially methylated regions through functional principal component analysis
- Testing differentially methylated regions through functional principal component analysis
Amanda Stillwell
Arkansas State University (US)
2 shared publications
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Meera Mohan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Manoj Kumar
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Rohan Samant
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Rudy Van Hemert
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Erming Tian
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience
Similar Researchers
Based on overlapping research topics
Melissa M. Frangie
Arkansas State University
Cancer Treatment and Pharmacology
Microbial infections and disease research
Metabolism and Genetic Disorders
Rick D. Edmondson
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Microbial infections and disease research
Metabolism and Genetic Disorders
Scott A. Stuart
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Bone Metabolism and Diseases
Metabolism and Genetic Disorders
Matthew Kusper
University of Arkansas at Little Rock
Cancer Treatment and Pharmacology
Microbial infections and disease research
Plant Physiology and Cultivation Studies
Ankur Varma
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Microbial infections and disease research
Metabolism and Genetic Disorders
Katie Dreher
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Microbial infections and disease research
Metabolism and Genetic Disorders